HITAP: มูลนิธิเพื่อการประเมินเทคโนโลยีและนโยบายด้านสุขภาพ Documents

English Policy Brief Collection – Volume 1

The English Policy Brief Collection (Volume 1) presents a selection of policy briefs published by the HITAP Foundation. These policy briefs have been ...Read more

27 November 2024 | 590

Policy Brief Issue 186 : Value Distribution in New Branded Medicines: How Much Benefits Patients Versus Manufacturers?

Thailand has successfully implemented economic evaluation to inform the inclusion of new, branded medicines within its National List of Essential Medi ...Read more

5 November 2024 | 560

Policy Brief Issue 29: Unveiling Thailand’s Path to Open Data for Health Policy

Open data is widely recognized as valuable, especially during the COVID-19 pandemic, highlighting the need for up-to-date information systems, leading ...Read more

19 December 2023 | 1655

Policy Brief Issue 26: Rare diseases – Talk of the Town for Some Time but What’s Next?

Because of their rarity, rare diseases are often treated with what the industry refers to as ‘orphan drugs’. These group of drugs are quite expensive ...Read more

15 August 2023 | 1642

Policy Brief Issue 25: South Korea’s Experience of Reimbursing High-Cost Medicines

Cost-effectiveness and availability of alternative treatment options play a crucial role in the listing of new medicines in South Korea. However, high ...Read more

12 June 2023 | 1982

Policy Brief Issue 24: Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review

This policy brief summarise findings from literature review on definition of 'rare disease,' and the use of HTA to support policy decisions around rar ...Read more

8 May 2023 | 561

Policy Brief Issue 24: Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review

This policy brief provides a summary of a recent review of the definition of rare diseases, high cost and how HTA has been used in the case of rare di ...Read more

8 May 2023 | 732

Policy Brief Issue 23: Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs

The Cancer Drug Fund (CDF) is a dedicated source of funding in England for increasing patient access to high-cost cancer drugs, with a fixed budget of ...Read more

20 March 2023 | 897

Policy Brief Issue 23: Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs

Cancer Drug Fund (CDF) เป็นกองทุนในอังกฤษเพื่อเพิ่มการเข้าถึงยารักษามะเร็งที่มีราคาสูง กองทุนนี้เริ่มดำเนินการมาตั้งแต่ พ.ศ. 2559 และมีงบประมาณ 340 ล้ ...Read more

20 March 2023 | 661

Policy Brief Issue 22: Horizon Scanning in the European Union

Horizon Scanning (HS) is the process of identifying new and emerging technologies before uptake into practice to evaluate the potential impact to info ...Read more

13 March 2023 | 690

Policy Brief

English Policy Brief Collection – Volume 1

Policy Brief Issue 186 : Value Distribution in New Branded Medicines: How Much Benefits Patients Versus Manufacturers?

Policy Brief Issue 29: Unveiling Thailand’s Path to Open Data for Health Policy

Policy Brief Issue 26: Rare diseases – Talk of the Town for Some Time but What’s Next?

Policy Brief Issue 25: South Korea’s Experience of Reimbursing High-Cost Medicines

Policy Brief Issue 24: Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review

Policy Brief Issue 24: Experience in Using HTA for Expanding UHC Benefit Package to Cover Rare Diseases and High-Cost Drugs among Seven Middle and High-Income Countries: A targeted literature review

Policy Brief Issue 23: Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs

Policy Brief Issue 23: Learning from Cancer Drug Fund (CDF) in England: A special reimbursement pathway for high-cost cancer drugs

Policy Brief Issue 22: Horizon Scanning in the European Union

Blog: Most Viewed

Follow Us on Twitter

Recent Posts

Categories

Archives

Menu

Follow Us On

Subscribe to our mailing list

HITAP เข้าสู่ระบบ

Policy Brief

Blog: Most Viewed

Follow Us on Twitter

Recent Posts

Categories

Archives

Tags

Menu

Follow Us On

Subscribe to our mailing list

Subscribe to our mailing list